相似文献
1
Refractory inflammatory myopathy in hematopoietic stem cell transplant patients with chronic graft-versus-host disease: report of two cases.
Hematol Transfus Cell Ther. 2019 Jul-Sep;41(3):268-271. doi: 10.1016/j.htct.2019.01.002. Epub 2019 Apr 24.
2
Severe sepsis in hematopoietic stem cell transplant recipients*.
Crit Care Med. 2015 Feb;43(2):411-21. doi: 10.1097/CCM.0000000000000714.
3
Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
Cytotherapy. 2001;3(4):253-60. doi: 10.1080/146532401317070880.
4
Risk of graft-versus-host disease with rituximab-containing conditioning regimens in allogeneic hematopoietic stem cell transplant.
J Oncol Pharm Pract. 2017 Jun;23(4):255-263. doi: 10.1177/1078155216637216. Epub 2016 Mar 11.
5
Rehabilitation in Chronic Graft-Versus-Host Disease.
Phys Med Rehabil Clin N Am. 2017 Feb;28(1):143-151. doi: 10.1016/j.pmr.2016.08.009.
6
Prophylactic Donor Lymphocyte Infusion (DLI) Followed by Minimal Residual Disease and Graft-versus-Host Disease-Guided Multiple DLIs Could Improve Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Refractory/Relapsed Acute Leukemia.
Biol Blood Marrow Transplant. 2017 Aug;23(8):1311-1319. doi: 10.1016/j.bbmt.2017.04.028. Epub 2017 May 5.
7
Allogeneic donor split skin grafts for treatment of refractory ulcers in cutaneous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation-a retrospective analysis on seven patients.
Ann Hematol. 2019 Aug;98(8):1867-1875. doi: 10.1007/s00277-019-03687-x. Epub 2019 Apr 16.
8
Risk factors predicting graft-versus-host disease and relapse-free survival after allogeneic hematopoietic stem cell transplantation in relapsed or refractory non-Hodgkin's lymphoma.
Ann Hematol. 2019 Jul;98(7):1743-1753. doi: 10.1007/s00277-019-03714-x. Epub 2019 May 14.
9
De novo postallogeneic hematopoietic stem cell transplant membranous nephropathy.
Exp Clin Transplant. 2013 Feb;11(1):75-8. doi: 10.6002/ect.2012.0078. Epub 2012 Jul 18.
10
Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice.
Haematologica. 2015 Sep;100(9):1228-36. doi: 10.3324/haematol.2015.124131. Epub 2015 Jun 18.
引用本文的文献
1
A likely case of chronic graft-versus-host disease polymyositis affecting respiratory and truncal muscles - a comprehensive diagnostic approach.
Blood Cell Ther. 2024 Sep 6;7(4):106-110. doi: 10.31547/bct-2023-040. eCollection 2024 Nov 25.
2
Musculoskeletal Chronic Graft versus Host Disease-A Rare Complication to Allogeneic Hematopoietic Stem Cell Transplant: A Case-Based Report and Review of the Literature.
Curr Oncol. 2022 Nov 3;29(11):8415-8430. doi: 10.3390/curroncol29110663.
3
Clinical Characteristics of Myositis Associated with Graft-Versus-Host Disease.
Curr Rheumatol Rep. 2021 Apr 24;23(5):30. doi: 10.1007/s11926-021-00996-x.
本文引用的文献
1
[Chronic GVHD complicated with polymyositis and cardiomyopathy after myeloablative hematopoietic stem cell transplantation].
Rinsho Ketsueki. 2015 May;56(5):485-90. doi: 10.11406/rinketsu.56.485.
2
Inflammatory muscle diseases.
N Engl J Med. 2015 Apr 30;372(18):1734-47. doi: 10.1056/NEJMra1402225.
3
NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.
Biol Blood Marrow Transplant. 2015 Apr;21(4):589-603. doi: 10.1016/j.bbmt.2014.12.031. Epub 2015 Jan 29.
4
Advances in graft-versus-host disease biology and therapy.
Nat Rev Immunol. 2012 May 11;12(6):443-58. doi: 10.1038/nri3212.
5
Graft-versus-host disease-related polymyositis.
Clin Rheumatol. 2010 Apr;29(4):431-33. doi: 10.1007/s10067-009-1350-5.
6
Chronic graft-versus-host disease.
Biol Blood Marrow Transplant. 2003 Apr;9(4):215-33. doi: 10.1053/bbmt.2003.50026.
7
Polymyositis as a manifestation of chronic graft-versus-host disease.
Rheumatology (Oxford). 2003 Jan;42(1):34-9. doi: 10.1093/rheumatology/keg025.
8
Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation.
Bone Marrow Transplant. 2002 Oct;30(8):543-6. doi: 10.1038/sj.bmt.1703711.
9
Recurrent acute myositis after allogeneic bone marrow transplantation for myelodysplasia.
Hematology. 2002 Apr;7(2):109-12. doi: 10.1080/10245330290022115.
10
Chronic graft-versus-host disease: clinical manifestation and therapy.
Bone Marrow Transplant. 2001 Jul;28(2):121-9. doi: 10.1038/sj.bmt.1703111.
Zotero 插件
